209 related articles for article (PubMed ID: 29073169)
1. Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
Johannessen C; Moi L; Kiselev Y; Pedersen MI; Dalen SM; Braaten T; Busund LT
PLoS One; 2017; 12(10):e0186658. PubMed ID: 29073169
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
5. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
[TBL] [Abstract][Full Text] [Related]
6. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer.
Rothé F; Ignatiadis M; Chaboteaux C; Haibe-Kains B; Kheddoumi N; Majjaj S; Badran B; Fayyad-Kazan H; Desmedt C; Harris AL; Piccart M; Sotiriou C
PLoS One; 2011; 6(6):e20980. PubMed ID: 21738599
[TBL] [Abstract][Full Text] [Related]
7. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
[TBL] [Abstract][Full Text] [Related]
10. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
Wu ZS; Wu Q; Wang CQ; Wang XN; Wang Y; Zhao JJ; Mao SS; Zhang GH; Zhang N; Xu XC
BMC Cancer; 2010 Oct; 10():542. PubMed ID: 20932331
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
13. The role of miR-100 in regulating apoptosis of breast cancer cells.
Gong Y; He T; Yang L; Yang G; Chen Y; Zhang X
Sci Rep; 2015 Jul; 5():11650. PubMed ID: 26130569
[TBL] [Abstract][Full Text] [Related]
14. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
Sempere LF; Christensen M; Silahtaroglu A; Bak M; Heath CV; Schwartz G; Wells W; Kauppinen S; Cole CN
Cancer Res; 2007 Dec; 67(24):11612-20. PubMed ID: 18089790
[TBL] [Abstract][Full Text] [Related]
15. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
[TBL] [Abstract][Full Text] [Related]
16. Is miR-144 an effective inhibitor of PTEN mRNA: a controversy in breast cancer.
Kia V; Sharif Beigli M; Hosseini V; Koochaki A; Paryan M; Mohammadi-Yeganeh S
In Vitro Cell Dev Biol Anim; 2018 Oct; 54(9):621-628. PubMed ID: 30132256
[TBL] [Abstract][Full Text] [Related]
17. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
[TBL] [Abstract][Full Text] [Related]
18. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
19. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.
Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L
Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883
[TBL] [Abstract][Full Text] [Related]
20. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
